CytoSorbents Q2 Revenue USD 9.633 Million
CTSO•Q2 results
CytoSorbents Q2 EPS USD -0.07.
- Q2 gross margin 73%
Related News
Ready Capital posts Q2 loss; CEO says earnings pressure narrowing
RC•
Monster Beverage FY26 Q2 net income rises 19.6% to $584.54 million; net sales climb 20.2% to $2.54 billion
MNST•
SoFi Q2 FY26 net income rises 61% to USD 156.59 million; revenue climbs 43% to USD 1.22 billion
SOFI•
I3 Verticals Q3 Revenue USD 53.067 Million Vs. IBES Estimate USD 55 Million
IIIV•
Reliance Global sells 251,666 shares to White Lion Capital for about $716,000
RELI•